OPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and Update

OPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and Update 
ROCHESTER, MI -- (Marketwired) -- 01/22/14 --  OPTIMIZERx Corp
(OTCQB: OPRX) today announced preliminary 2013 fourth quarter
results. 
The Company is forecasting fourth quarter 2013 revenue of
approximately $1.884 million, bringing revenue for 2013 to
approximately $5.030 Million -- an increase of 245% over 2012, when
revenue was $2,048,699 million. 
The Company's Chairman and CEO, Mr. David Harrell, stated, "We are
very excited for the continued growth we're experiencing in all
facets of our business, evidenced by another record quarter. We
anticipate continued growth in 2014 and beyond as we expand our
electronic pipeline to deliver savings and product support to
hundreds of thousands of doctors -- right at point of care." 
OPTIMIZERx Corp. provides unique consumer and physician platforms to
help patients better afford and comply with their medicines and
healthcare products, while offering pharmaceutical and healthcare
companies effective ways to expand patient awareness, access and
adherence to their brands. For more information, please go to
www.optimizerxcorp.com. 
'SAFE HARBOR'  
This press release contains forward-looking statements within the
definition of Section 27A of the Securities Act of 1933, as amended
and such section 21E of the Securities Act of 1934, amended. These
forward-looking statements should not be used to make an investment
decision. The words 'estimate,' 'possible' and 'seeking' and similar
expressions identify forward-looking statements, which speak only as
to the date the statement was made. The company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise. Forward-looking statements are inherently subject to risks
and uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect of
government regulation, competition and other material risks.  
Investor Contact: 
Chris Schreiber
cs@taglich.com
(917) 445-6207